News & Events

Sidekick Health, Alumni company within the Accelerator at Sahlgrenska Science Park and member of HealthTech Nordic, has been recognized as an international champion of digital health research and innovation, and chosen to partner for the White House's CancerX initiative announced by U.S. President Joe Biden and Dr. Jill Biden. The aim is to rapidly accelerate the pace of cancer innovation in the US.

Resan mot de nya läkemedlen har bara börjat, men visionen är att kunna bota det vi idag kan behandla, lindra eller bara stödja – svåra handikapp från barnaåren, diabetes, hjärtsvikt och inte minst de maligna sjukdomarna.

​​​​​​​His main interest is to design solutions to needs in complex environments with a human-centered perspective, primarily as an implementer and facilitator, but also as an active coordinator and researcher. What could be more appropriate in his new role as a Site Director for Sahlgrenska Science Park? Meet Karl Maack, focusing on projects, talent attraction and building a strong site community.

The initiative Next Stop gives detailed overview of the structure, collaboration and funding opportunties with leading partners of the world’s largest healthcare markets.

Inkubatorer i Västsverige ser en positiv trend för kvinnligt entreprenörskap. De senaste åren har närmare 10% fler kvinnor deltagit i de aktiviteter som anordnas av West Swedish Incubators, ett samarbete mellan åtta inkubatorer i Västsverige som verkar för att fler hållbara innovationsföretag från regionen skall etablera sig på en internationell marknad.

Resan mot de nya läkemedlen har bara börjat, men visionen är att kunna bota det vi idag kan behandla, lindra eller bara stödja – svåra handikapp från barnaåren, diabetes, hjärtsvikt och inte minst de maligna sjukdomarna.

Exciting news from the Accelerator

This year’s Arvid Carlsson Award by Sahlgrenska Science Park was awarded to Filip Peters, Acorai, for turning smartphones into heart failure monitoring devices. With more than 60 million patients suffering from heart failure globally, the winner of the Arvid Carlsson Award 2022 is addressing a huge health and healthcare problem, by using new technologies to simplify the diagnosis and follow-up care. 

​​​​​​​Maria Fuxborg has more than 20 years of experience in different leading positions within marketing, communications and public affairs in Gothenburg based companies characterized by high-end technology and innovation. Meet her at Park Annual, 30 November.

Next to AstraZeneca research site in Mölndal a new city district is being developed to bring together companies, organizations, and individuals within the field of health. With over 200 000 square meters, GoCo Health Innovation City develop an innovative cluster for health, where collaboration is built into the core. Meet the team behind GoCo Health Innovation City at Park Annual, 30 November.

​​​​​​​Astra Zeneca’s ambition is to go from treating symptoms to curing, or even reversing, disease. Matti Ahlqvist, Executive Director for the Gothenburg site, share his view on why collaboration and sustainability is critical for the life science industry and what people coming to Park Annual 30 November can look forward to.

The nomination period to the Arvid Carlsson Award is closed and the work and process of choosing this year's winner has begun by a prominent jury.